Khalid Usman, Mujeeb ur Rehman, Arif Mumtaz, Naseeb UrRehman, and Salman Khan, “EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION”, J Popl Ther Clin Pharmacol, vol. 28, no. 2, pp. 418–422, Jul. 2021.